Some patients prefer IV drips for more comprehensive wellness, while others use injections for maintenance or quick energy boosts
Large US claims database analyses continue to refine our understanding of both absolute and relative risk compared to other diabetes therapies
It took the brand manufacturers more than two years to build enough capacity for the FDA to declare the shortages over, which happened on December 19, 2024, for Eli Lillys tirzepatide products, and February 21, 2025, for Novo Nordisks semaglutide products
Because of the effects GLP-1 agonists have on digestion, the most common side effects for these medications are gastrointestinal problems, like (Tran, 2017): Nausea Vomiting Constipation Diarrhea Bloating Indigestion GLP-1 may worsen symptoms of severe gastroesophageal reflux (acid reflux or heartburn) and gastroparesisa condition where the stomach doesnt move food around as well and doesnt fully empty (Hinnen, 2017)